Studies into the effect of tyrosine phosphatase inhibitor phenylarsine oxide on NFκB activation in T lymphocytes during aging: Evidence for altered IκB-α phosphorylation and degradation

Experimental Gerontology

Volumn 34, Issue 1, 1999, Pages 95-107

  Ponnappan, Usha ^a   Trebilcock, Gina U ^a   Zheng, Ming Zhong ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Aging and NF B; I B ; PAO; Proteasome; Protein phosphorylation; Signaling; Transcription factor

Indexed keywords

ARSENOSOBENZENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; PROTEIN TYROSINE PHOSPHATASE INHIBITOR;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ARSENICALS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HUMANS; I-KAPPA B PROTEINS; MULTIENZYME COMPLEXES; NF-KAPPA B; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE-PHOSPHATASE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033009202     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00059-X     Document Type: Article

References (21)

1. Adamczewski M., Paolini R., Kinet J.P. Evidence for two distinct phosphorylation pathways activated by high affinity immunoglobulin E receptors. J. Biol. Chem. 267:1992;18126.
2. Bajpai A., Bramhi Z. Sulfhydryl reactive phenylarsine oxide inhibits signal transduction in NK and LAK cells Effect on zeta-chain phosphorylation and phosphatidylinositol level . Biochim. Biophys. Acta. 1177:1993;291.
3. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Jr. TNF and IL-1 lead to phosphorylation and loss of IκBα A mechanism for NFκB activation . Mol. Cell. Biol. 13:1993;3301.
4. Druker B.J., Neumann M., Okuda K., Franza B.R. Jr, Griffi J.D. Rel is rapidly tyrosine phosphorylated following GM-CSF treatment in human neutrophils. J. Biol. Chem. 269:1994;5387.
5. Fletcher M.C., Samelson L.E., June C.H. Complex effects of PAO in T cells. J. Biol. Chem. 268:1993;23697.
6. Fu H., Sadis S., Rubin D.M., Glickman M., Van-Nocker S., Finley D., Vierstra R.D. Multiubiquitin chain binding an protein degradation are mediated by distinct domains within the 26S proteasome subunit Mcb1. J. Biol. Chem. 273:1998;1970.
7. Ghosh S., May M.J., Kopp E.B. NfκB and rel proteins Evolutionarily conserved mediators of immune responses . Annu. Rev. Immunol. 16:1998;225.
8. Harhaj E.W., Sun S.-C. The serine threonine phosphatase inhibitor calyculin A induces rapid degradation of IκB-beta. J. Biol. Chem. 272:1997;5409.
9. Imbert V., Rupec R.A., Livolsi A., Pahl H.L., Traenckner E.B., Mueller-Dieckmann C., Farahifar D., Rossi B., Auberger P., Baeuerle P.A., Peyron J.-F. Tyrosine phosphorylation of IκB-α activates NfκB without proteolytic degradation of IκB-α Cell. 86:1996;787.
10. Kato Y., Sato H., Ichikawa M., Suzuki H., Sawada Y., Hanano M., Fuwa T., Sugiyama Y. Existence of two pathways for the endocytosis of epidermal growth factor by rat liver Phenylarsine oxide-sensitive and -insensitive pathways . Proc. Natl. Acad. Sci. USA. 89:1992;8507.
11. Kresja C.M., Nadler S.G., Esselstyn J.M., Kavanagh T.J., Ledbetter J.A., Schieven G.L. Role of oxidative stress in the action of Vanadium phosphotyrosine phosphotase inhibitors. J. Biol. Chem. 272:1997;11541.
12. Kung C., Thomas M.L. Recent advances in lymphocyte signaling and regulation. Front. Biosci. 2:1997;d207.
13. Liao K., Hoffman R.D., Lane M.D. Phosphotyrosyl turnover in insulin signaling. Characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J. Biol. Chem. 266:1991;6544.
14. Mahon T.M., O'Neill L.A.J. Studies into the effect of tyrosine kinase inhibitor Herbimycin A on NfκB activation in T lymphocytes. J. Biol. Chem. 270:1995;28557.
15. Miller R.A. The aging immune system Primer and prospectus . Science. 273:1996;70.
16. Singh S., Aggarwal B.B. Protein tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NfκB. J. Biol. Chem. 270:1995;10631.
17. Thevenin C., Seong J.K., Rieckman P., Fujiki H., Norcross M.A., Sporn M.B., Fauci A.S., Kehri J.H. Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. New Biol. 2:1990;793.
18. Trebilcock G.U., Ponnappan U. Induction and regulation of NFκB during aging Role of protein kinases . Clin. Immunol. Immunopathol. 79:1996;7.
19. Trebilcock G.U., Ponnappan U. Lowered induction of NFκB in activated human T lymphocytes during aging. Gerontology. 42:1996;137.
20. Wang C.-Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis Potentiation by inhibition of NFκB . Science. 274:1996;784.
21. Whisler R.L., Beiqing L., Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors API and NF-AT. Cell Immunol. 169:1996;185-195.